Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

KZIA Kazia Therapeutics Ltd

3,40

0,00 (0,00%)

18 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Kazia Therapeutics Charts.

Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Kazia Therapeutics Charts.

News Kazia Therapeutics Ltd

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 11 Dezember 2024 (7 Tage vor) • Edgar (US Regulatory)

Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium
Mittwoch 11 Dezember 2024 (7 Tage vor) • PR Newswire (US)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 3 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 3 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Dienstag 3 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Mittwoch 27 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Mittwoch 27 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Freitag 15 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 12 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Donnerstag 7 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 4 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Kazia Therapeutics Ltd News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen